These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7260907)

  • 21. Effect of high-protein diet on pyrimidine synthesis and response to PALA in mouse tissues.
    Zaharevitz DW; Grubb MF; Hyman R; Chisena C; Cysyk RL
    J Natl Cancer Inst; 1993 Apr; 85(8):662-6. PubMed ID: 8468725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
    Lyons SD; Sant ME; Christopherson RI
    J Biol Chem; 1990 Jul; 265(19):11377-81. PubMed ID: 2358467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I and clinical pharmacological evaluation of biochemical modulation of 5-fluorouracil with N-(phosphonacetyl)-L-aspartic acid.
    Casper ES; Vale K; Williams LJ; Martin DS; Young CW
    Cancer Res; 1983 May; 43(5):2324-9. PubMed ID: 6831457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma.
    Ardalan B; Glazer RI; Kensler TW; Jayaram HN; Van Pham T; Macdonald JS; Cooney DA
    Biochem Pharmacol; 1981 Aug; 30(15):2045-9. PubMed ID: 7295324
    [No Abstract]   [Full Text] [Related]  

  • 25. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
    Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
    Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.
    Cory AH; Cory JG
    Biochem Biophys Res Commun; 1998 Aug; 249(3):687-91. PubMed ID: 9731198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells.
    Hindenburg AA; Taub RN; Grant S; Chang G; Baker MA
    Cancer Res; 1985 Jul; 45(7):3048-52. PubMed ID: 3859365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical pharmacology of acivicin in rat hepatoma cells.
    Lui MS; Kizaki H; Weber G
    Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic interaction between acivicin (AT-125) and 6-thioguanine in the murine leukemia L1210. Biochemical and cytokinetic considerations.
    Bhalla K; Nayak R; Deitch A; Grant S
    Biochem Pharmacol; 1984 Jan; 33(2):247-54. PubMed ID: 6200115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of the clinical pharmacology of N-phosphonacetyl-L-aspartate (PALA), a new antimetabolite.
    Erlichman C
    Recent Results Cancer Res; 1980; 74():65-71. PubMed ID: 7444150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells.
    Yang JL; Fernandes DJ; Wheeler KT; Capizzi RL
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1073-9. PubMed ID: 8600090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells.
    Ahmed N; Weidemann MJ
    Leuk Res; 1995 Apr; 19(4):263-73. PubMed ID: 7538618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase.
    Nelson J; Qureshi IA; Vasudevan S; Sarma DS
    Chem Biol Interact; 1993 Oct; 89(1):35-47. PubMed ID: 8221965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells.
    Tsuboi KK; Edmunds NH; Kwong LK
    Cancer Res; 1977 Sep; 37(9):3080-7. PubMed ID: 884665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overproduction of the first three enzymes of pyrimidine nucleotide biosynthesis in Drosophila cells resistant to N-phosphonacetyl-L-aspartate.
    Laval M; Azou Y; Giorgi D; Rosset R
    Exp Cell Res; 1986 Apr; 163(2):381-95. PubMed ID: 2869965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological and biochemical interactions of N-(phosphonacetyl)-L-aspartate and 5-fluorouracil in beagles.
    Miller AA; Moore EC; Hurlbert RB; Benvenuto JA; Loo TL
    Cancer Res; 1983 Jun; 43(6):2565-70. PubMed ID: 6189583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
    Liang CM; Donehower RC; Chabner BA
    Mol Pharmacol; 1982 Jan; 21(1):224-30. PubMed ID: 6813676
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Jayaram HN; Ardalan B; Deas M; Johnson RK
    Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined action of acivicin and D-galactosamine on pyrimidine nucleotide metabolism in hepatoma cells.
    Leube K; Keppler DO
    Biochem Pharmacol; 1983 Jun; 32(12):1865-9. PubMed ID: 6882463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.